ACE2 and breast carcinoma: In the luminal breast cancer, ACE2 is related to the immune infiltration of CD8+ T cells (r = 0.184, p < 0.001), CD4+ T cells (r = 0.104, p = 0.02) and neutrophils (r = 0.101, p = 0.02).